Cefepime Induced Encephalopathy in a Non-dialysis Dependent Chronic Kidney Disease Patient: A Case Report

Acta Med Indones. 2023 Jan;55(1):78-82.

Abstract

Cefepime is a frequently used fourth-generation cephalosporin antibiotic for a wide variety of infections. Toxic levels of this drug can cause neurological complications. The most common neurological adverse event of cefepime is headache and lightheadedness. Here, we presented a case of cefepime induced encephalopathy in a 57-year-old female patient with acute on chronic kidney disease. With an accurate diagnosis that requires a high index of clinical suspicion, prompt management was instituted. She had full resolution of symptoms following discontinuation of the medication and also emergent dialysis.

Keywords: Cefepime; chronic kidney disease; encephalopathy.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Brain Diseases* / chemically induced
  • Brain Diseases* / drug therapy
  • Cefepime / adverse effects
  • Cephalosporins / adverse effects
  • Female
  • Humans
  • Middle Aged
  • Renal Insufficiency, Chronic* / complications
  • Renal Insufficiency, Chronic* / therapy

Substances

  • Cefepime
  • Cephalosporins
  • Anti-Bacterial Agents